Management of Metastatic Bone Disease and Hypercalcemia of Malignancy

This publication has 8 references indexed in Scilit:

• Bisphosphonates: from the laboratory to the clinic and back again
  Bone, 1999
• Myeloma bone disease
  European Journal Of Cancer, 1998
• Concomitant i.v. and oral clodronate in the relief of bone pain – a double-blind placebo-controlled study in patients with prostate cancer
  British Journal of Cancer, 1997
• PROTEIN PRENYLATION: Molecular Mechanisms and Functional Consequences
  Annual Review of Biochemistry, 1996
• The effect of clodronate on bone in metastatic prostate cancer. Histomorphometric report of a double-blind randomised placebo-controlled study
  European Journal Of Cancer, 1994
• In VivoStimulation of Endosteal Bone Formation by Basic Fibroblast Growth Factor in Rats
  Growth Factors, 1993
• Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma
  The Lancet, 1992
• Protective Effects of a Prophylactic Treatment with the Bisphosphonate 3-Amino-1 -Hydroxypropane-1,1 -Bisphosphonic Acid on the Development of Tumor Osteopathies in the Rat: Experimental Studies with the Walker Carcinosarcoma 256
  Oncology, 1988